Posted by Michael Wonder on 18 Jun 2018
Eli Lilly CEO: 'It's time for a change' in the drug pricing system
14 June 2018 - Ricks says pharmacy benefit managers, or PBMs, are benefiting from price increases.
As prescription drug prices continue to soar, Eli Lilly and Company CEO David Ricks told CNBC that reducing the gap between list prices and what consumers pay is a "good idea."
"It's time for a change of the system," Ricks told CNBC's Meg Tirrell on "Power Lunch" Thursday.
